NEOZOTAC is a national , multicenter , randomized study comparing the efficacy of TAC ( docetaxel , adriamycin and cyclophosphamide i.v. ) followed by granulocyte colony-stimulating factor on day 2 with or without ZA 4 mg i.v. q 3 weeks inpatients withstage II/III , HER2-negative BC .